Table of Contents Author Guidelines Submit a Manuscript
Table of Contents Alerts

To receive news and publication updates for Stroke Research and Treatment, enter your email address in the box below.

Stroke Research and Treatment
Volume 2012, Article ID 839151, 8 pages
http://dx.doi.org/10.1155/2012/839151
Review Article

Small Vessel Cerebrovascular Disease: The Past, Present, and Future

Réza Behrouz,1,2 Ali R. Malek,3 and Michel T. Torbey1,2

1Division of Cerebrovascular Diseases & Neurocritical Care, Department of Neurology, The Ohio State University College of Medicine, 395 West 12th Avenue, 7th Floor, Suite 766, Columbus, OH 43210, USA
2Neurovascular Stroke Center, The Ohio State University Medical Center, 395 West 12th Avenue, 7th Floor, Columbus, OH 43210, USA
3Interventional Neurology Program, Comprehensive Stroke Center, St. Mary's Medical Center, 901 45th Street, West Palm Beach, FL 33407, USA

Received 19 September 2011; Accepted 26 October 2011

Academic Editor: Chelsea S. Kidwell

Copyright © 2012 Réza Behrouz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. P. Adams Jr., B. H. Bendixen, L. J. Kappelle et al., “Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial,” Stroke, vol. 24, no. 1, pp. 35–41, 1993. View at Google Scholar
  2. C. M. Fisher, “Lacunar strokes and infarcts: a review,” Cerebrovascular Diseases, vol. 1, pp. 311–320, 1991. View at Google Scholar
  3. S. Sacco, C. Marini, R. Totaro, T. Russo, D. Cerone, and A. Carolei, “A population-based study of the incidence and prognosis of lacunar stroke,” Neurology, vol. 66, no. 9, pp. 1335–1338, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. C. M. Fisher, “Lacunar strokes and infarcts: a review,” Neurology, vol. 32, no. 8, pp. 871–876, 1982. View at Google Scholar · View at Scopus
  5. C. M. Fisher, “The arterial lesions underlying lacunes,” Acta Neuropathologica, vol. 12, no. 1, pp. 1–15, 1969. View at Publisher · View at Google Scholar · View at Scopus
  6. G. De Jong, F. Kessels, and J. Lodder, “Two types of lacunar infarcts: further arguments from a study on prognosis,” Stroke, vol. 33, no. 8, pp. 2072–2076, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Boiten, J. Lodder, and F. Kessels, “Two clinically distinct lacunar infarct entities? A hypothesis,” Stroke, vol. 24, no. 5, pp. 652–656, 1993. View at Google Scholar · View at Scopus
  8. D. R. Horowitz, S. Tuhrim, J. M. Weinberger, and S. H. Rudolph, “Mechanisms in lacunar infarction,” Stroke, vol. 23, no. 3, pp. 325–327, 1992. View at Google Scholar · View at Scopus
  9. N. Futrell, “Lacumar infarction: embolism is the key,” Stroke, vol. 35, no. 7, pp. 1778–1779, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. R. L. Macdonald, A. Kowalczuk, and L. Johns, “Emboli enter penetrating arteries of monkey brain in relation to their size,” Stroke, vol. 26, no. 7, pp. 1247–1251, 1995. View at Google Scholar · View at Scopus
  11. R. L. Sacco, S. Prabhakaran, J. L. P. Thompson et al., “Comparison of warfarin versus aspirin for the prevention of recurrent stroke or death: subgroup analyses from the warfarin-aspirin recurrent stroke study,” Cerebrovascular Diseases, vol. 22, no. 1, pp. 4–12, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Arboix, A. Font, C. Garro, L. García-Eroles, E. Comes, and J. Massons, “Recurrent lacunar infarction following a previous lacunar stroke: a clinical study of 122 patients,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 78, no. 12, pp. 1392–1394, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Soda, H. Nakayasu, M. Maeda et al., “Stroke recurrence within the first year following cerebral infarction—Tottori University Lacunar Infarction Prognosis Study (TULIPS),” Acta Neurologica Scandinavica, vol. 110, no. 6, pp. 343–349, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Arauz, L. Murillo, C. Cantú, F. Barinagarrementeria, and J. Higuera, “Prospective study of single and multiple lacunar infarcts using magnetic resonance imaging: risk factors, recurrence, and outcome in 175 consecutive cases,” Stroke, vol. 34, no. 10, pp. 2453–2458, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Gan, R. L. Sacco, D. E. Kargman, J. K. Roberts, B. Boden-Albala, and Q. Gu, “Testing the validity of the lacunar hypothesis: the northern Manhattan stroke study experience,” Neurology, vol. 48, no. 5, pp. 1204–1211, 1997. View at Google Scholar · View at Scopus
  16. I. L. H. Knottnerus, M. Gielen, J. Lodder et al., “Family history of stroke is an independent risk factor for lacunar stroke subtype with asymptomatic lacunar infarcts at younger ages,” Stroke, vol. 42, no. 5, pp. 1196–1200, 2011. View at Publisher · View at Google Scholar
  17. J. Jannes, M. A. Hamilton-Bruce, L. Pilotto et al., “Tissue plasminogen activator -7351C/T enhancer polymorphism is a risk factor for lacunar stroke,” Stroke, vol. 35, no. 5, pp. 1090–1094, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Pullicino, P. L. Kwen, S. Greenberg, A. L. Becker, and N. Glenister, “Angiotensin-converting enzyme gene and lacunar stroke,” Stroke, vol. 27, no. 3, pp. 569–570, 1996. View at Google Scholar · View at Scopus
  19. A. Chamorro, M. Revilla, V. Obach, M. Vargas, and A. M. Planas, “The -174G/C polymorphism of the interleukin 6 gene is a hallmark of lacunar stroke and not other ischemic stroke phenotypes,” Cerebrovascular Diseases, vol. 19, no. 2, pp. 91–95, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Revilla, V. Obach, Á. Cervera, A. Dávalos, J. Castillo, and Á. Chamorro, “A -174G/C polymorphism of the interleukin-6 gene in patients with lacunar infarction,” Neuroscience Letters, vol. 324, no. 1, pp. 29–32, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. I. Clavier, M. Hommel, G. Besson, B. Noèlle, and J. E. F. Perret, “Long-term prognosis of symptomatic lacunar infarcts: a hospital-based study,” Stroke, vol. 25, no. 10, pp. 2005–2009, 1994. View at Google Scholar · View at Scopus
  22. S. Melkas, J. Putaala, N. K. Oksala et al., “Small-vessel disease relates to poor poststroke survival in a 12-year follow-up,” Neurology, vol. 76, no. 8, pp. 734–739, 2011. View at Publisher · View at Google Scholar
  23. B. Norrving, “Long-term prognosis after lacunar infarction,” Lancet Neurology, vol. 2, no. 4, pp. 238–245, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. W. Steinke and S. C. Ley, “Lacunar stroke is the major cause of progressive motor deficits,” Stroke, vol. 33, no. 6, pp. 1510–1516, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. A. V. Salgado, J. M. Ferro, and A. Gouveia-Oliveira, “Long-term prognosis of first-ever lacunar strokes: a hospital-based study,” Stroke, vol. 27, no. 4, pp. 661–666, 1996. View at Google Scholar · View at Scopus
  26. K. L. Furie, S. E. Kasner, R. J. Adams et al., “Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association,” Stroke, vol. 42, pp. 227–276, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. Z. Chen, P. Sandercock, H. Pan et al., “Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40 000 randomized patients from the Chinese Acute Stroke Trial and the International Stroke Trial,” Stroke, vol. 31, no. 6, pp. 1240–1249, 2000. View at Google Scholar
  28. J. P. Mohr, J. L. P. Thompson, R. M. Lazar et al., “A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke,” New England Journal of Medicine, vol. 345, no. 20, pp. 1444–1451, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. F. Gotoh, H. Tohgi, S. Hirai et al., “Cilostazol stroke prevention study: a placebo-controlled double-blind trial for secondary prevention of cerebral infarction,” Journal of Stroke and Cerebrovascular Diseases, vol. 9, no. 4, pp. 147–157, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Shinohara, Y. Katayama, S. Uchiyama et al., “Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial,” The Lancet Neurology, vol. 9, no. 10, pp. 959–968, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Collins, J. Armitage, S. Parish, P. Sleight, and R. Peto, “Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions,” The Lancet, vol. 363, no. 9411, pp. 757–767, 2004. View at Google Scholar
  32. P. Amarenco, J. Bogousslavsky, A. Callahan et al., “High-dose atorvastatin after stroke of transient ischemic attack. The stroke prevention by aggressive reduction in cholesterol levels study (SPARCL),” New England Journal of Medicine, vol. 355, pp. 549–559, 2006. View at Google Scholar
  33. Y. H. Fan, V. C. T. Mok, W. W. M. Lam, A. C. F. Hui, and K. S. Wong, “Cerebral microbleeds and white matter changes in patients hospitalized with lacunar infarcts,” Journal of Neurology, vol. 251, no. 5, pp. 537–541, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. L. B. Goldstein, P. Amarenco, M. Szarek et al., “Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study,” Neurology, vol. 70, no. 24, pp. 2364–2370, 2008. View at Google Scholar · View at Scopus
  35. P. C. Lavallée, J. Labreuche, F. Gongora-Rivera et al., “Placebo-controlled trial of high-dose atorvastatin in patients with severe cerebral small vessel disease,” Stroke, vol. 40, no. 5, pp. 1721–1728, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. National Institute of Neurological Disorders and Stroke rt-PAStroke Study Group, “Tissue plasminogen activator for acute ischemic stroke,” New England Journal of Medicine, vol. 333, no. 24, pp. 1581–1587, 1995. View at Publisher · View at Google Scholar
  37. L. R. Caplan, “Penetrating and branch artery disease,” in Stroke: A Clinical Approach, L. R. Caplan, Ed., pp. 291–315, Saunders, Philadelphia, Pa, USA, 4th edition, 2009. View at Google Scholar
  38. T. J. Ingall, W. M. O'Fallon, K. Asplund et al., “Findings from the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial,” Stroke, vol. 35, no. 10, pp. 2418–2424, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. D. Inzitari, M. Eliasziw, B. L. Sharpe, A. J. Fox, and H. J. Barnett, “Risk factors and outcome of patients with carotid artery stenosis presenting with lacunar stroke,” Neurology, vol. 54, no. 3, pp. 660–666, 2000. View at Google Scholar
  40. J. Boiten, P. M. Rothwell, J. Slattery, and C. P. Warlow, “Ischaemic lacunar stroke in the European Carotid Surgery Trial. Risk factors, distribution of carotid stenosis, effect of surgery and type of recurrent stroke,” Cerebrovascular Diseases, vol. 6, no. 5, pp. 281–287, 1996. View at Google Scholar
  41. J. Tejada, E. Díez-Tejedor, L. Hernández-Echebarría, and O. Balboa, “Does a relationship exist between carotid stenosis and lacunar infarction?” Stroke, vol. 34, no. 6, pp. 1404–1409, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Silvestrini, P. Pasqualetti, R. Baruffaldi et al., “Cerebrovascular reactivity and cognitive decline in patients with Alzheimer disease,” Stroke, vol. 37, no. 4, pp. 1010–1015, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Jackson and C. Sudlow, “Comparing risks of death and recurrent vascular events between lacunar and non-lacunar infarction,” Brain, vol. 128, no. 11, pp. 2507–2517, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. I. L. H. Knottnerus, J. W. P. Govers-Riemslag, K. Hamulyak et al., “Endothelial activation in lacunar stroke subtypes,” Stroke, vol. 41, no. 8, pp. 1617–1622, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Hassan, B. J. Hunt, M. O'Sullivan et al., “Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis,” Brain, vol. 126, no. 2, pp. 424–432, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Castellanos, J. Castillo, M. M. García et al., “Inflammation-mediated damage in progressing lacunar infarctions a potential therapeutic target,” Stroke, vol. 33, no. 4, pp. 982–987, 2002. View at Publisher · View at Google Scholar · View at Scopus
  47. M. G. Cortina, A. R. Campello, J. J. Conde et al., “Monocyte count is an underlying marker of lacunar subtype of hypertensive small vessel disease,” European Journal of Neurology, vol. 15, no. 7, pp. 671–676, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. M. S. V. Elkind, J. M. Luna, C. S. Coffey et al., “The levels of inflammatory markers in the treatment of stroke study (limits): inflammatory biomarkers as risk predictors after lacunar stroke,” International Journal of Stroke, vol. 5, no. 2, pp. 117–125, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. P. Jerrard-Dunne, G. Cloud, A. Hassan, and H. S. Markus, “Evaluating the genetic component of ischemic stroke subtypes: a family history study,” Stroke, vol. 34, no. 6, pp. 1364–1369, 2003. View at Publisher · View at Google Scholar · View at Scopus
  50. J. F. Meschia, B. M. Kissela, T. G. Brott et al., “The Siblings With Ischemic Stroke Study (SWISS): a progress report,” Clinical Medicine and Research, vol. 4, no. 1, pp. 12–21, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. T. J. Huynh, B. Murphy, J. A. Pettersen et al., “CT perfusion quantification of small-vessel ischemic severity,” American Journal of Neuroradiology, vol. 29, no. 10, pp. 1831–1836, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. N. S. Rost, R. M. Rahman, A. Biffi et al., “White matter hyperintensity volume is increased in small vessel stroke subtypes,” Neurology, vol. 75, no. 19, pp. 1670–1677, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. A. A. Gouw, A. Seewann, W. M. Van Der Flier et al., “Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 82, no. 2, pp. 126–135, 2011. View at Publisher · View at Google Scholar
  54. R. L. Sacco, H. C. Diener, S. Yusuf et al., “Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke,” New England Journal of Medicine, vol. 359, no. 12, pp. 1238–1251, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. S. Yusuf, H. C. Diener, R. L. Sacco et al., “Telmisartan to prevent recurrent stroke and cardiovascular events,” New England Journal of Medicine, vol. 359, no. 12, pp. 1225–1237, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. O. R. Benavente, C. L. White, L. Pearce et al., “The Secondary Prevention of Small Subcortical Strokes (SPS3) study,” International Journal of Stroke, vol. 6, no. 2, pp. 164–175, 2011. View at Publisher · View at Google Scholar